YD Bio Limited Ordinary Shares
- YDES
- NASDAQ
- Biotechnology
- Cancer Diagnostics
- Exosome Therapeutics
$5.78
Today −2.45%Quote Oct 19, 2026, 02:03 PM UTC
+82.72%over the last month
Max drawdown −28.6%From 1-month high −27.0%3 months +160.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$409.1M
Quote Oct 19
Next earnings
—
Data unavailable
Latest analyst target
—
Data unavailable
Floor
$5.35
7.4% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about YDESPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
14
Founded
2013